title: Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure.
authors: Department of Dermatology, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
authors: C
authors: http://orcid.org/0000-0003-1447-5982
authors: C
authors: Champagne
authors: Department of Cellular Pathology, Brighton and Sussex University Hospitals, Brighton, UK.
authors: M
authors: M
authors: Taylor
authors: Department of Dermatology, Brighton and Sussex University Hospitals, Brighton, UK.
authors: P
authors: P
authors: Farrant
mesh_terms: D000328:Adult; D000505:Alopecia / Q000139:chemically induced*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002066:Busulfan / Q000009:adverse effects; D005260:Female; D006801:Humans; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced*; D013852:Thiotepa / Q000009:adverse effects; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D013852:Thiotepa; D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine